scholarly article | Q13442814 |
P50 | author | Mehmet Ali Ergun | Q57334076 |
Clyde B Schechter | Q87050955 | ||
Diana Miglioretti | Q88168881 | ||
Amy Trentham-Dietz | Q88960210 | ||
Jeanne S Mandelblatt | Q90278289 | ||
Brian L Sprague | Q91924355 | ||
Karla Kerlikowske | Q92299671 | ||
Nicolien T van Ravesteyn | Q98198718 | ||
Anna N. A. Tosteson | Q110143968 | ||
Aimee M Near | Q114374862 | ||
Natasha K Stout | Q114563134 | ||
Jeroen J van den Broek | Q114563144 | ||
Oğuzhan Alagöz | Q56654355 | ||
Ronald E Gangnon | Q56810665 | ||
P2093 | author name string | John M Hampton | |
Harry J de Koning | |||
Breast Cancer Surveillance Consortium and the Cancer Intervention and Surveillance Modeling Network | |||
Young Chandler | |||
P2860 | cites work | Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis | Q24628928 |
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status | Q27012792 | ||
The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model | Q27347267 | ||
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society | Q27347760 | ||
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease | Q30665466 | ||
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease | Q30747351 | ||
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. | Q33792616 | ||
Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies | Q33957073 | ||
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits | Q34159375 | ||
Prevalence of mammographically dense breasts in the United States | Q34354391 | ||
Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer | Q61881608 | ||
The impact of a breast cancer screening programme on quality-adjusted life-years | Q68009566 | ||
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999 | Q79220367 | ||
The Wisconsin Breast Cancer Epidemiology Simulation Model | Q79220380 | ||
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement | Q34508652 | ||
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality | Q34736052 | ||
Identifying women with dense breasts at high risk for interval cancer: a cohort study | Q35646902 | ||
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials | Q35740423 | ||
Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer | Q36090967 | ||
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies | Q36368636 | ||
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk | Q36460671 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Performance benchmarks for screening mammography | Q36600843 | ||
Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality | Q36619874 | ||
Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis | Q36770273 | ||
Progress Toward Consensus on Breast Cancer Screening Guidelines and Reducing Screening Harms | Q36908218 | ||
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy | Q36976948 | ||
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness | Q37139381 | ||
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies | Q37364628 | ||
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women | Q37480990 | ||
Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. | Q37548461 | ||
Breast cancer risk associated with benign breast disease: systematic review and meta-analysis | Q38338001 | ||
Benefits and Harms of Breast Cancer Screening: A Systematic Review | Q38616415 | ||
Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index | Q38627432 | ||
Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation | Q38693328 | ||
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold | Q39268069 | ||
Family history and the risk of breast cancer: a systematic review and meta-analysis | Q41495151 | ||
Breast-cancer screening--viewpoint of the IARC Working Group | Q41697220 | ||
Alcohol consumption and ethyl carbamate. | Q42730898 | ||
Convergence and Divergence Around Breast Cancer Screening | Q44026572 | ||
Nurses' health study: log-incidence mathematical model of breast cancer incidence | Q44198064 | ||
Mammographic screening programmes in Europe: organization, coverage and participation | Q45328273 | ||
The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods. | Q50192553 | ||
Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. | Q51914599 | ||
A breast cancer prediction model incorporating familial and personal risk factors. | Q52000310 | ||
Retrospective cost-effectiveness analysis of screening mammography. | Q53241570 | ||
Cost of care for elderly cancer patients in the United States. | Q53730492 | ||
Modeling the dissemination of mammography in the United States | Q56940783 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
collaboration | Q1145523 | ||
breast cancer screening | Q17011492 | ||
P304 | page(s) | 700-712 | |
P577 | publication date | 2016-08-23 | |
P1433 | published in | Annals of Internal Medicine | Q564416 |
P1476 | title | Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes | |
P478 | volume | 165 |
Q91621376 | "You probably can't feel as safe as normal women": Hispanic women's reactions to breast density notification |
Q57593829 | Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis |
Q92654615 | Age-based versus Risk-based Mammography Screening in Women 40-49 Years Old: A Cross-sectional Study |
Q64880735 | Assessing Patient Interest in Individualized Preventive Care Recommendations. |
Q64914458 | Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study. |
Q60175951 | Breast Cancer Incidence by Stage Before and After Change in Screening Guidelines |
Q87909686 | Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening |
Q92528444 | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification |
Q47304201 | Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening. |
Q51738440 | Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology. |
Q57177092 | Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model |
Q92437923 | Discussions of Dense Breasts, Breast Cancer Risk, and Screening Choices in 2019 |
Q52350449 | Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment. |
Q92307692 | Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes |
Q64092231 | Health professionals' perspectives on breast cancer risk stratification: understanding evaluation of risk versus screening for disease |
Q90678404 | How Do Women View Risk-Based Mammography Screening? A Qualitative Study |
Q90690238 | Interval breast cancer risk associations with breast density, family history and breast tissue aging |
Q92006924 | Personalized breast cancer screening strategies: A systematic review and quality assessment |
Q96577047 | Personalized early detection and prevention of breast cancer: ENVISION consensus statement |
Q38984143 | Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer |
Q52648599 | Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia. |
Q47094586 | Simulation modeling for stratified breast cancer screening - a systematic review of cost and quality of life assumptions. |
Q55037632 | The combined effect of mammographic texture and density on breast cancer risk: a cohort study. |
Q60175954 | Trends in breast cancer mortality by stage at diagnosis among young women in the United States |
Q58793591 | Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study |
Q91594655 | Willingness to decrease mammogram frequency among women at low risk for hereditary breast cancer |
Search more.